Skip to Main Content

Paper Details

A clinically applicable integrative molecular classification of meningiomas.
Nature
191
2021
DNA, Meningiomas, NF2, NF2 wild, Patients, Single, meningioma, meningiomas, meningiomas2, messenger RNA, neoplastic, neoplastic cells, primary intracranial tumour, tumour
Biomarkers, Tumor, DNA Methylation, Data Analysis, Drug Discovery, Female, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Male, Meningioma, Mutation, Proteogenomics, RNA-Seq, Reproducibility of Results, Single-Cell Analysis
Author NameAffiliation
Farshad NassiriPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Farshad NassiriUniversity of Toronto
Farshad Nassiri
Jeff LiuPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Jeff Liu
Vikas PatilPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Vikas Patil
Yasin MamatjanPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Yasin Mamatjan
Justin Z WangPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Justin Z WangUniversity of Toronto
Justin Z Wang
Rupert Hugh-WhiteJonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California los angeles
Andrew MacklinPrincess Margaret Cancer Centre, University Health Network
Shahbaz KhanPrincess Margaret Cancer Centre, University Health Network
Olivia SinghPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Shirin KarimiPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Rosario I CoronaJonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California los angeles
Lydia Y LiuJonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California los angeles
Lydia Y LiuUniversity of Toronto
Caroline Y ChenJonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California los angeles
Ankur ChakravarthyPrincess Margaret Cancer Centre, University Health Network
Qingxia WeiPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Bharati MehaniCenter for Cancer Research, National Cancer Institute
Suganth SuppiahPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Suganth SuppiahUniversity of Toronto
Suganth Suppiah
Andrew GaoUniversity Health Network
Adriana M WorkewychPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Ghazaleh Tabatabai
Ghazaleh TabatabaiHertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tubingen
Paul C Boutros
Paul C BoutrosJonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California los angeles
Paul C BoutrosUniversity of California los angeles
Gary D BaderUniversity of Toronto
Gary D BaderUniversity of Toronto
Gary D BaderUniversity of Toronto
Gary D BaderThe Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Daniel D De CarvalhoPrincess Margaret Cancer Centre, University Health Network
Daniel D De CarvalhoUniversity of Toronto
Thomas Kislinger
Thomas KislingerUniversity of Toronto
Thomas KislingerPrincess Margaret Cancer Centre, University Health Network
Thomas Kislinger
Thomas KislingerPrincess Margaret Cancer Centre, University Health Network
Thomas KislingerUniversity of Toronto
Kenneth AldapePrincess Margaret Cancer Centre, University Health Network and University of Toronto
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Kenneth Aldape
Kenneth AldapePrincess Margaret Cancer Centre, University Health Network and University of Toronto
  • 1 - 50

Datasets